ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)
Clinical trial NCT02955615 · COMPLETED
Trial details
- NCT number
- NCT02955615
- Sponsor
- Iltoo Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-18
- Primary completion
- 2018-08-27
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.